-
1
-
-
0029837761
-
How tumors become angiogenic
-
Bouck, N.; Stellmach, V.; Hsu, S.C. How tumors become angiogenic. Adv. Cancer Res. 1996, 69, 135-174.
-
(1996)
Adv. Cancer Res
, vol.69
, pp. 135-174
-
-
Bouck, N.1
Stellmach, V.2
Hsu, S.C.3
-
2
-
-
0029121235
-
Angiogenesis: Mechanistic insights, nanovascular diseases, and therapeutic prospects
-
Battegay, E.J. Angiogenesis: Mechanistic insights, nanovascular diseases, and therapeutic prospects. J. Mol. Med. 1995, 73, 333-346.
-
(1995)
J. Mol. Med
, vol.73
, pp. 333-346
-
-
Battegay, E.J.1
-
3
-
-
77953677226
-
Angiogenesis inhibition in prostate cancer: Current uses and future promises
-
doi:10.1155/2010/361836
-
Aragon-Ching, J.B.; Madan, R.A.; Dahut, W.T. Angiogenesis inhibition in prostate cancer: Current uses and future promises. J. Oncol. 2010, doi:10.1155/2010/361836.
-
(2010)
J. Oncol
-
-
Aragon-Ching, J.B.1
Madan, R.A.2
Dahut, W.T.3
-
4
-
-
84867844763
-
Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxities
-
Cohen, R.B.; Oudard, S. Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxities. Invest. New Drugs 2012, 30, 2066-2079.
-
(2012)
Invest. New Drugs
, vol.30
, pp. 2066-2079
-
-
Cohen, R.B.1
Oudard, S.2
-
5
-
-
0037274880
-
Thrombospondins as anti-angiogenic therapeutic agents
-
Vailhé, B.; Feige, J.J. Thrombospondins as anti-angiogenic therapeutic agents. Curr. Pharm. Des. 2003, 9, 583-588.
-
(2003)
Curr. Pharm. Des
, vol.9
, pp. 583-588
-
-
Vailhé, B.1
Feige, J.J.2
-
6
-
-
80054761310
-
Phase II randomized double blind placebo-controlled study to determine the efficacy of tasquinimod in asymptomatic patients with metastatic castrate-resistant prostate cancer
-
Pili, R.; Häggman, M.; Stadler, W.M.; Gingrich, J.; Assikis, V.; Björk, A.; Nordle, O.; Fosrsberg, G.; Carducci, M.A.; Armstrong, A.J. Phase II randomized double blind placebo-controlled study to determine the efficacy of tasquinimod in asymptomatic patients with metastatic castrate-resistant prostate cancer. J. Clin. Oncol. 2011, 29, 4022-4028.
-
(2011)
J. Clin. Oncol
, vol.29
, pp. 4022-4028
-
-
Pili, R.1
Häggman, M.2
Stadler, W.M.3
Gingrich, J.4
Assikis, V.5
Björk, A.6
Nordle, O.7
Fosrsberg, G.8
Carducci, M.A.9
Armstrong, A.J.10
-
8
-
-
0035178990
-
Thronbospondins: Multifuctional regulators of cell interactions
-
Adams, J.C. Thronbospondins: Multifuctional regulators of cell interactions. Annu. Rev. Cell Div. Biol. 2001, 17, 25-51.
-
(2001)
Annu. Rev. Cell Div. Biol
, vol.17
, pp. 25-51
-
-
Adams, J.C.1
-
9
-
-
0018253429
-
Isolated and characterisation of a high molecular weight glycoprotein from human blood platelet
-
Lawler, J.; Slayter, H.S.; Coligan, J.E. Isolated and characterisation of a high molecular weight glycoprotein from human blood platelet. J. Biol. Chem. 1978, 253, 8609-8616.
-
(1978)
J. Biol. Chem
, vol.253
, pp. 8609-8616
-
-
Lawler, J.1
Slayter, H.S.2
Coligan, J.E.3
-
10
-
-
38349132563
-
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling
-
Isenberg, J.S.; Romeo, M.J.; Yu, C.; Yu, C.K.; Nghiem, K.; Monsale, J.; Rick, M.E.; Wink, D.A.; Fraizier, W.A.; Roberts, D.D. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 2008, 111, 613-623.
-
(2008)
Blood
, vol.111
, pp. 613-623
-
-
Isenberg, J.S.1
Romeo, M.J.2
Yu, C.3
Yu, C.K.4
Nghiem, K.5
Monsale, J.6
Rick, M.E.7
Wink, D.A.8
Fraizier, W.A.9
Roberts, D.D.10
-
11
-
-
0021933434
-
Monocytes and macrophages synthesize and secrete thrombospondin
-
Jaffe, E.A.; Ruggiero, J.T.; Falcone, D.J. Monocytes and macrophages synthesize and secrete thrombospondin. Blood 1985, 65, 78-84.
-
(1985)
Blood
, vol.65
, pp. 78-84
-
-
Jaffe, E.A.1
Ruggiero, J.T.2
Falcone, D.J.3
-
12
-
-
0023875603
-
Cell surface thrombospondin is functionally essential for vascular smooth muscle cells proliferation
-
Majack, R.A.; Goodman, L.V.; Dixit, V.M. Cell surface thrombospondin is functionally essential for vascular smooth muscle cells proliferation. J. Cell Biol. 1988, 106, 415-422.
-
(1988)
J. Cell Biol
, vol.106
, pp. 415-422
-
-
Majack, R.A.1
Goodman, L.V.2
Dixit, V.M.3
-
13
-
-
0035049231
-
Thoronbospondins as matricelular modulators of cell function
-
Bornstein, P. Thoronbospondins as matricelular modulators of cell function. J. Clin. Invest. 2001, 107, 929-934.
-
(2001)
J. Clin. Invest
, vol.107
, pp. 929-934
-
-
Bornstein, P.1
-
14
-
-
0027216767
-
-
Reed, M.J.; Puolakkainen, P.; Lane, T.F.; Dickerson, D.; Bornstein, P.; Sage, E.H. Different expression of SPARC and thrombospondin 1 in wound repair: Immunolocalization and in situ hybridization. J. Histochem. Cytochem. 1993, 41, 1467-1477.
-
(1993)
Different Expression of SPARC and Thrombospondin 1 In Wound Repair: Immunolocalization and In Situ Hybridization
, vol.41
, pp. 1467-1477
-
-
Reed, M.J.1
Puolakkainen, P.2
Lane, T.F.3
Dickerson, D.4
Bornstein, P.5
Sage, E.H.6
-
15
-
-
78149288324
-
Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation
-
Bauer, E.M.; Qin, Y.; Miller, T.W.; Bandle, R.W.; Csanyi, G.; Pagano, P.J.; Bauer, P.M.; Schnermann, J.; Roberts, D.D.; Isenberg, J.S. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc. Res. 2010, 88, 471-481.
-
(2010)
Cardiovasc. Res
, vol.88
, pp. 471-481
-
-
Bauer, E.M.1
Qin, Y.2
Miller, T.W.3
Bandle, R.W.4
Csanyi, G.5
Pagano, P.J.6
Bauer, P.M.7
Schnermann, J.8
Roberts, D.D.9
Isenberg, J.S.10
-
16
-
-
80052333271
-
Thrombospondin-1: Multiple paths to inflammation
-
doi:10.1155/2011/296069
-
Lopez-Dee, Z.; Pidcock, K.; Gutierrez, L.S. Thrombospondin-1: Multiple paths to inflammation. Mediators Inflamm. 2011, doi:10.1155/2011/296069.
-
(2011)
Mediators Inflamm
-
-
Lopez-Dee, Z.1
Pidcock, K.2
Gutierrez, L.S.3
-
17
-
-
0029347102
-
Diversity of function is inherent in matricelluar proteins: An appraisal of thrombospondin 1
-
Bornstein, P. Diversity of function is inherent in matricelluar proteins: An appraisal of thrombospondin 1. J. Cell Biol. 1995, 130, 503-506.
-
(1995)
J. Cell Biol
, vol.130
, pp. 503-506
-
-
Bornstein, P.1
-
18
-
-
58949086991
-
Thrombospondin in renal disease
-
Hugo, C.; Daniel, C.; Thrombospondin in renal disease. Exper. Nephrol. 2009, 111, e61-e66.
-
(2009)
Exper. Nephrol
, vol.111
-
-
Hugo, C.1
Daniel, C.2
-
19
-
-
0029955545
-
Expression of thrombospondin-1 in cancer: A role in tumor progression
-
Qian, X.; Tuszynski, G.P. Expression of thrombospondin-1 in cancer: A role in tumor progression. Proc. Soc. Exp. Biol. Med. 1996, 212, 199-207.
-
(1996)
Proc. Soc. Exp. Biol. Med
, vol.212
, pp. 199-207
-
-
Qian, X.1
Tuszynski, G.P.2
-
20
-
-
0025370524
-
Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor
-
Taraboletti, G.; Roberts, D.D.; Liotta, L.A.; Giavazzi, R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor. J. Cell Biol. 1990, 111, 765-772.
-
(1990)
J. Cell Biol
, vol.111
, pp. 765-772
-
-
Taraboletti, G.1
Roberts, D.D.2
Liotta, L.A.3
Giavazzi, R.4
-
21
-
-
0031193866
-
Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thorombospondin-1
-
Tolsma, S.S.; Stack, M.S.; Bouck, N. Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thorombospondin-1. Microvasc. Res. 1997, 54, 13-26.
-
(1997)
Microvasc. Res
, vol.54
, pp. 13-26
-
-
Tolsma, S.S.1
Stack, M.S.2
Bouck, N.3
-
22
-
-
0342445431
-
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
-
Jimenez, B.; Volpert, O.V.; Crawford, S.E.; Febbraio, M.; Silverstein, R.L.; Bouck, N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 2000, 6, 41-48.
-
(2000)
Nat. Med
, vol.6
, pp. 41-48
-
-
Jimenez, B.1
Volpert, O.V.2
Crawford, S.E.3
Febbraio, M.4
Silverstein, R.L.5
Bouck, N.6
-
23
-
-
0032521539
-
Molecular mediators of angiogenesis in bladder cancer
-
Cambells, S.C.; Volpert, O.V.; Ivanovich, M.; Bouck, N.P. Molecular mediators of angiogenesis in bladder cancer. Cancer Res. 1998, 58, 1298-1304.
-
(1998)
Cancer Res
, vol.58
, pp. 1298-1304
-
-
Cambells, S.C.1
Volpert, O.V.2
Ivanovich, M.3
Bouck, N.P.4
-
24
-
-
0036362236
-
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth
-
Lawler, J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J. Cell Mol. Med. 2002, 6, 1-12.
-
(2002)
J. Cell Mol. Med
, vol.6
, pp. 1-12
-
-
Lawler, J.1
-
25
-
-
0037360164
-
Thrombospondins 1 and 2 function as inhibitors of angiogenesis
-
Armstrong, L.C.; Bormstein, P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol. 2003, 22, 63-71.
-
(2003)
Matrix Biol
, vol.22
, pp. 63-71
-
-
Armstrong, L.C.1
Bormstein, P.2
-
26
-
-
33645348277
-
-
Karavasilis, V.; malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Pavlidis, N. Clinicopathological study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma. Int. J. Gynecol. Cancer 2006, 16, 241-246.
-
(2006)
Clinicopathological Study of Vascular Endothelial Growth Factor, Thrombospondin-1, and Microvessel Density Assessed By CD34 In Patients With Stage III Ovarian Carcinoma
, vol.16
, pp. 241-246
-
-
Karavasilis, V.1
Malamou-Mitsi, V.2
Briasoulis, E.3
Tsanou, E.4
Kitsou, E.5
Pavlidis, N.6
-
27
-
-
0031572311
-
Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells
-
Qian, X.; Wang, T.N.; Rothman, V.L.; Nicosia, R.F.; Tuszynski, G.P. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp. Cell Res. 1997, 235, 403-412.
-
(1997)
Exp. Cell Res
, vol.235
, pp. 403-412
-
-
Qian, X.1
Wang, T.N.2
Rothman, V.L.3
Nicosia, R.F.4
Tuszynski, G.P.5
-
28
-
-
84892901800
-
CD36 mediates the in vitro inhibitory effects of thrombospondin-1 have anti-angiogenic activity
-
Dawson, D.M.; Pearce, S.F.; Zhong, R.; Silverstein, R.L.; Frazier, W.A.; Bouck, N.P. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 1997, 138, 7070-7717.
-
(1997)
J. Cell Biol
, vol.138
, pp. 7070-7717
-
-
Dawson, D.M.1
Pearce, S.F.2
Zhong, R.3
Silverstein, R.L.4
Frazier, W.A.5
Bouck, N.P.6
-
29
-
-
0031710790
-
CD36 mediates binding of soluble thrombospondin-1 but not cell adhesion and haptotaxis on immobilized thrombospondin-1
-
Magnetto, S.; Bruno-Bossio, G.; Voland, C.; Lecerf, J.; Lawler, J.; Delmas, P.; Silverstein, R.; Clezardin, P. CD36 mediates binding of soluble thrombospondin-1 but not cell adhesion and haptotaxis on immobilized thrombospondin-1. Cell Biochem. Funct. 1998, 16, 211-221.
-
(1998)
Cell Biochem. Funct
, vol.16
, pp. 211-221
-
-
Magnetto, S.1
Bruno-Bossio, G.2
Voland, C.3
Lecerf, J.4
Lawler, J.5
Delmas, P.6
Silverstein, R.7
Clezardin, P.8
-
30
-
-
0033818794
-
The functions of TSP-1 and TSP-2a
-
Lawler, J. The functions of TSP-1 and TSP-2a. Curr. Opin. Cell Biol. 2000, 12, 634-650.
-
(2000)
Curr. Opin. Cell Biol
, vol.12
, pp. 634-650
-
-
Lawler, J.1
-
31
-
-
60749091126
-
Regulation of nitric oxide signaling by thrombospondin 1: Implications for anti-angiogenic therapies
-
Isenberg, J.S.; Martin-Manso, G.; Maxhimer, J.B.; Roberts, D.D. Regulation of nitric oxide signaling by thrombospondin 1: Implications for anti-angiogenic therapies. Nat. Rev. Cancer 2009, 9, 182-194.
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 182-194
-
-
Isenberg, J.S.1
Martin-Manso, G.2
Maxhimer, J.B.3
Roberts, D.D.4
-
32
-
-
0029797025
-
Regulation of tumor growth and metastasis by thrombospondin-1
-
Roberts, D.D. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB. J. 1996, 10, 1183-1191.
-
(1996)
FASEB. J
, vol.10
, pp. 1183-1191
-
-
Roberts, D.D.1
-
33
-
-
0031057680
-
Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: Correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia
-
Bertin, N.; Clezardin, P.; Kubiak, R.; Frappart, T. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: Correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Res. 1997, 57, 396-399.
-
(1997)
Cancer Res
, vol.57
, pp. 396-399
-
-
Bertin, N.1
Clezardin, P.2
Kubiak, R.3
Frappart, T.4
-
34
-
-
0033427081
-
Expression of angiostatic factors in colorectal cancer
-
Yoshida, Y.; Oshika, Y.; Fukushima, Y.; Tokunaga, T.; Hatanaka, H.; Kijima, H.; Yamazaki, H.; Ueyama, Y.; Tamaoki, N.; Miura, S.; et al. Expression of angiostatic factors in colorectal cancer. Int. J. Oncol. 1999, 15, 1221-1225.
-
(1999)
Int. J. Oncol
, vol.15
, pp. 1221-1225
-
-
Yoshida, Y.1
Oshika, Y.2
Fukushima, Y.3
Tokunaga, T.4
Hatanaka, H.5
Kijima, H.6
Yamazaki, H.7
Ueyama, Y.8
Tamaoki, N.9
Miura, S.10
-
35
-
-
19244385544
-
Stromal thrombospondin-1 expression is correlated with progression of esophagus squamous cell carcinoma
-
Oshiba, G.; Kijima, H.; Himeno, S.; Kenmochi, T.; Kise, Y.; Tanaka, H.; Nishi, T.; Chino, O.; Shimada, H.; Machimura, T.; et al. Stromal thrombospondin-1 expression is correlated with progression of esophagus squamous cell carcinoma. Anticancer Res. 1999, 19, 4375-4378.
-
(1999)
Anticancer Res
, vol.19
, pp. 4375-4378
-
-
Oshiba, G.1
Kijima, H.2
Himeno, S.3
Kenmochi, T.4
Kise, Y.5
Tanaka, H.6
Nishi, T.7
Chino, O.8
Shimada, H.9
Machimura, T.10
-
36
-
-
0034658412
-
Thrombospondin-1 is down regulated by anoxia and suppresses tumorgenicity of human glioblastoma cells
-
Tenan, M.; Fulci, G.; Albertoni, M.; Diserens, A.C.; Hamou, M.F.; el Atifi-Borel, M.; Feige, J.J.; Pepper, M.S.; van Meir, E.G. Thrombospondin-1 is down regulated by anoxia and suppresses tumorgenicity of human glioblastoma cells. J. Exp. Med. 2000, 191, 1789-1798.
-
(2000)
J. Exp. Med
, vol.191
, pp. 1789-1798
-
-
Tenan, M.1
Fulci, G.2
Albertoni, M.3
Diserens, A.C.4
Hamou, M.F.5
El, A.-B.M.6
Feige, J.J.7
Pepper, M.S.8
van Meir, E.G.9
-
37
-
-
83655191245
-
Therapies using anti-angiogenic peptide mimetics of thrombospondin-1
-
Henkin, J.; Volpert, O.V. Therapies using anti-angiogenic peptide mimetics of thrombospondin-1. Expert. Opin. Ther. Targets 2011, 15, 1369-1386.
-
(2011)
Expert. Opin. Ther. Targets
, vol.15
, pp. 1369-1386
-
-
Henkin, J.1
Volpert, O.V.2
-
38
-
-
0031979317
-
Mutant p53 correlates with reduced expression of thrombospondin-1, increasing angiogenesis and metastatic progression in melanoma
-
Grant, S.W.; Kyshtoobayeva, A.S.; Kurosaki, T.; Jakowatz, J.; Fruehauf, J.P. Mutant p53 correlates with reduced expression of thrombospondin-1, increasing angiogenesis and metastatic progression in melanoma. Cancer Detect. Prev. 1998, 22, 185-194.
-
(1998)
Cancer Detect. Prev
, vol.22
, pp. 185-194
-
-
Grant, S.W.1
Kyshtoobayeva, A.S.2
Kurosaki, T.3
Jakowatz, J.4
Fruehauf, J.P.5
-
39
-
-
3442888565
-
Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis
-
Wu, M.P.; Tzeng, C.C.; Wu, L.W.; Huang, K.F.; Chou, C.Y. Thrombospondin-1 acts as a fence to inhibit angiogenesis that occurs during cervical carcinogenesis. Cancer J. 2004, 10, 27-32.
-
(2004)
Cancer J
, vol.10
, pp. 27-32
-
-
Wu, M.P.1
Tzeng, C.C.2
Wu, L.W.3
Huang, K.F.4
Chou, C.Y.5
-
40
-
-
38449086640
-
Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer
-
Byrne, G.J.; Hayden, K.E.; McDowell, G.; Lang, H.; Kirwan, C.C.; Tetlow, L.; Kumar, S.; Bundred, N.J. Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer. Int. J. Oncol. 2007, 31, 1127-1132.
-
(2007)
Int. J. Oncol
, vol.31
, pp. 1127-1132
-
-
Byrne, G.J.1
Hayden, K.E.2
McDowell, G.3
Lang, H.4
Kirwan, C.C.5
Tetlow, L.6
Kumar, S.7
Bundred, N.J.8
-
41
-
-
79959832634
-
Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer
-
Nakao, T.; Kurita, N.; Komatsu, M.; Yoshikawa, K.; Iwata, T.; Utsunomiya, T.; Shimada, M. Expression of thrombospondin-1 and Ski are prognostic factors in advanced gastric cancer. Int. J. Clin. Oncol. 2011, 16, 145-152.
-
(2011)
Int. J. Clin. Oncol
, vol.16
, pp. 145-152
-
-
Nakao, T.1
Kurita, N.2
Komatsu, M.3
Yoshikawa, K.4
Iwata, T.5
Utsunomiya, T.6
Shimada, M.7
-
42
-
-
33645737997
-
Angiogenesis in cholangiocellular carcinoma: Expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance
-
Tang, D.; Nagano, H.; Yamamoto, H.; Wada, H.; Nakamura, M.; Kondo, M.; Otam, H.; Yoshioka, S.; Kato, H.; Damdinsuren, B.; et al. Angiogenesis in cholangiocellular carcinoma: Expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. Oncol. Rep. 2006, 15, 525-532.
-
(2006)
Oncol. Rep
, vol.15
, pp. 525-532
-
-
Tang, D.1
Nagano, H.2
Yamamoto, H.3
Wada, H.4
Nakamura, M.5
Kondo, M.6
Otam, H.7
Yoshioka, S.8
Kato, H.9
Damdinsuren, B.10
-
43
-
-
0035940429
-
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor
-
Rodriguez-Manzaneque, J.C.; Lane, T.F.; Ortega, M.A.; Hynes, R.O.; Lawler, J.; Iruela-Arispe, M.L. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA 2001, 98, 12485-12490.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 12485-12490
-
-
Rodriguez-Manzaneque, J.C.1
Lane, T.F.2
Ortega, M.A.3
Hynes, R.O.4
Lawler, J.5
Iruela-Arispe, M.L.6
-
44
-
-
0036875337
-
Expression and role of thrombospondin-1 in colorectal cancer
-
Miyanaga, K.; Kato, Y.; Nakamura, T.; Matsumura, M.; Amaya, H.; Horiuchi, T.; Chiba, Y.; Tanaka, K. Expression and role of thrombospondin-1 in colorectal cancer. Anticancer Res. 2002, 22, 3941-3948.
-
(2002)
Anticancer Res
, vol.22
, pp. 3941-3948
-
-
Miyanaga, K.1
Kato, Y.2
Nakamura, T.3
Matsumura, M.4
Amaya, H.5
Horiuchi, T.6
Chiba, Y.7
Tanaka, K.8
-
45
-
-
84857763650
-
Thrombospondin-1 expression in breast cancer: Prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components
-
Ioachim, E.; Damala, K.; Tsanou, E.; Briasoulis, E.; Papadiotis, E.; Mitselou, A.; Charhanti, A.; Doukas, M.; Lampri, L.; Arvantis, D.L. Thrombospondin-1 expression in breast cancer: Prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components. Histol. Histopathol. 2012, 27, 209-216.
-
(2012)
Histol. Histopathol
, vol.27
, pp. 209-216
-
-
Ioachim, E.1
Damala, K.2
Tsanou, E.3
Briasoulis, E.4
Papadiotis, E.5
Mitselou, A.6
Charhanti, A.7
Doukas, M.8
Lampri, L.9
Arvantis, D.L.10
-
46
-
-
0036096954
-
Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma
-
Tanaka, K.; Sonoo, H.; Kurebayashi, J.; Nomura, T.; Ohkubo, S.; Yamamoto, Y.; Yamamoto, S. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma. Clin. Cancer Res. 2002, 8, 1125-1131.
-
(2002)
Clin. Cancer Res
, vol.8
, pp. 1125-1131
-
-
Tanaka, K.1
Sonoo, H.2
Kurebayashi, J.3
Nomura, T.4
Ohkubo, S.5
Yamamoto, Y.6
Yamamoto, S.7
-
47
-
-
0029931502
-
Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer
-
Wang, T.N.; Qian, X.-H.; Granick, M.S.; Solomon, M.P.; Rothman, V.L.; Berger, D.H.; Tuszynski, G.P. Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. J. Surg. Res. 1996, 63, 39-43.
-
(1996)
J. Surg. Res
, vol.63
, pp. 39-43
-
-
Wang, T.N.1
Qian, X.-H.2
Granick, M.S.3
Solomon, M.P.4
Rothman, V.L.5
Berger, D.H.6
Tuszynski, G.P.7
-
48
-
-
49949152493
-
Thrombospondin-1 enhances human thyroid carcinoma cell invasion though urokinase activity
-
Sid, B.; Langlois, B.; Sartelet, H.; Bellon, G.; Dedieu, S.; Martiny, L. Thrombospondin-1 enhances human thyroid carcinoma cell invasion though urokinase activity. Int. J. Biochem. Cell Biol. 2008, 40, 1890-1900.
-
(2008)
Int. J. Biochem. Cell Biol
, vol.40
, pp. 1890-1900
-
-
Sid, B.1
Langlois, B.2
Sartelet, H.3
Bellon, G.4
Dedieu, S.5
Martiny, L.6
-
49
-
-
58849135842
-
The effect of thrombospondin-1 on breast cancer metastasis
-
Yee, K.O.; Connolly, C.M.; Duquette, M.; Kazerounian, S.; Washington, R.; Lawler, J. The effect of thrombospondin-1 on breast cancer metastasis. Breast Cancer Res. Treat. 2009, 114, 85-96.
-
(2009)
Breast Cancer Res. Treat
, vol.114
, pp. 85-96
-
-
Yee, K.O.1
Connolly, C.M.2
Duquette, M.3
Kazerounian, S.4
Washington, R.5
Lawler, J.6
-
50
-
-
25144508039
-
Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis
-
Sutton, C.D.; O'Byrne, K.; Goddard, J.C.; Marshall, L.J.; Jones, L.; Garcea, G.; Dennison, A.R.; Poston, G.; Lloyd, D.M.; Berry, D.P. Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis. Clin. Cancer Res. 2005, 11, 6567-6573.
-
(2005)
Clin. Cancer Res
, vol.11
, pp. 6567-6573
-
-
Sutton, C.D.1
O'Byrne, K.2
Goddard, J.C.3
Marshall, L.J.4
Jones, L.5
Garcea, G.6
Dennison, A.R.7
Poston, G.8
Lloyd, D.M.9
Berry, D.P.10
-
51
-
-
84255192004
-
Thrombospondin-1 triggers cell migration and development of advanced prostate tumors
-
Firlej, V.; Mathieu, J.R.R.; Gilbert, C.; Lemonnier, L.; Nakhlé, J.; Gallou-Kabani, C.; Guarmit, B.; Morin, A.; Prevarskaya, N.; Delomgchamps, N.B.; et al. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors. Cancer Res. 2011, 71, 7649-7656.
-
(2011)
Cancer Res
, vol.71
, pp. 7649-7656
-
-
Firlej, V.1
Mathieu, J.R.R.2
Gilbert, C.3
Lemonnier, L.4
Nakhlé, J.5
Gallou-Kabani, C.6
Guarmit, B.7
Morin, A.8
Prevarskaya, N.9
Delomgchamps, N.B.10
-
52
-
-
0035403794
-
Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer
-
Maeda, K.; Nishiguchi, Y.; Kang, S.M.; Yashiro, M.; Onoda, N.; Sawada, T.; Ishikawa, T.; Hirakawa, K. Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol. Rep. 2001, 8, 763-766.
-
(2001)
Oncol. Rep
, vol.8
, pp. 763-766
-
-
Maeda, K.1
Nishiguchi, Y.2
Kang, S.M.3
Yashiro, M.4
Onoda, N.5
Sawada, T.6
Ishikawa, T.7
Hirakawa, K.8
-
53
-
-
84886582937
-
VEGF and TSP1 correlate with prognosis in advanced non-small cell lung cancer
-
doi:10.1007/s12094-013-1020-6
-
Fleitas, T.; Martínez-sales, V.; Villa, V.; Reganon, E.; Mesado, D.; Martín, M.; Gómez-Cordina, J.; Montalar, J.; Reynés, G. VEGF and TSP1 correlate with prognosis in advanced non-small cell lung cancer. Clin. Transl. Oncol. 2013, doi:10.1007/s12094-013-1020-6.
-
(2013)
Clin. Transl. Oncol
-
-
Fleitas, T.1
Martínez-Sales, V.2
Villa, V.3
Reganon, E.4
Mesado, D.5
Martín, M.6
Gómez-Cordina, J.7
Montalar, J.8
Reynés, G.9
-
54
-
-
0036903517
-
Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast
-
Rice, A.J.; Steward, M.A.; Quinn, C.M. Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast. J. Clin. Pathol. 2002, 55, 921-955.
-
(2002)
J. Clin. Pathol
, vol.55
, pp. 921-955
-
-
Rice, A.J.1
Steward, M.A.2
Quinn, C.M.3
-
55
-
-
3042670492
-
Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma
-
Poon, R.T.; Chung, K.K.; Cheung, S.T.; Lau, C.P.; Tong, S.W.; Leung, K.L.; Yu, W.C.; Tuszynski, G.P.; Fan, S.T. Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma. Clin. Cancer Res. 2004, 15, 4150-4157.
-
(2004)
Clin. Cancer Res
, vol.15
, pp. 4150-4157
-
-
Poon, R.T.1
Chung, K.K.2
Cheung, S.T.3
Lau, C.P.4
Tong, S.W.5
Leung, K.L.6
Yu, W.C.7
Tuszynski, G.P.8
Fan, S.T.9
-
56
-
-
0037079243
-
Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice
-
Hawighorst, T.; Oura, H.; Streit, M.; Janes, L.; Nguyen, L.; Brown, L.F.; Oliver, G.; Jackson, D.G.; Detmar, M. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 2002, 21, 7945-7956.
-
(2002)
Oncogene
, vol.21
, pp. 7945-7956
-
-
Hawighorst, T.1
Oura, H.2
Streit, M.3
Janes, L.4
Nguyen, L.5
Brown, L.F.6
Oliver, G.7
Jackson, D.G.8
Detmar, M.9
-
57
-
-
0034747320
-
Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate
-
Doll, J.A.; Reiher, F.K.; Crawford, S.E.; Pins, M.R.; Campbell, S.C.; Bouck, N.P. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate 2001, 49, 293-305.
-
(2001)
Prostate
, vol.49
, pp. 293-305
-
-
Doll, J.A.1
Reiher, F.K.2
Crawford, S.E.3
Pins, M.R.4
Campbell, S.C.5
Bouck, N.P.6
-
58
-
-
77954147694
-
Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-activation
-
Fitchev, P.P.; Wcislak, S.M.; Lee, C.; Bergh, A.; Brendler, C.B.; Stellmach, V.M.; Crawford, S.E.; Marvroudis, C.D.; Cornwell, M.L.; Doll, J.A. Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-activation. Lab. Invest. 2010, 90, 1078-1090.
-
(2010)
Lab. Invest
, vol.90
, pp. 1078-1090
-
-
Fitchev, P.P.1
Wcislak, S.M.2
Lee, C.3
Bergh, A.4
Brendler, C.B.5
Stellmach, V.M.6
Crawford, S.E.7
Marvroudis, C.D.8
Cornwell, M.L.9
Doll, J.A.10
-
59
-
-
0025147371
-
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable form a fragment of thrombospondin
-
Good, D.J.; Polverini, P.J.; Rastinejad, F.; Le, B.M.; Lemons, R.S.; Frazier, W.A.; Bouck, N.P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable form a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 1990, 87, 6624-6628.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 6624-6628
-
-
Good, D.J.1
Polverini, P.J.2
Rastinejad, F.3
Le, B.M.4
Lemons, R.S.5
Frazier, W.A.6
Bouck, N.P.7
-
60
-
-
0034493883
-
The application of an antiangiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenograft model
-
Jin, R.J.; Kwak, C.; Ree, S.G. The application of an antiangiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenograft model. Cancer Gene Ther. 2000, 7, 1537-1542.
-
(2000)
Cancer Gene Ther
, vol.7
, pp. 1537-1542
-
-
Jin, R.J.1
Kwak, C.2
Ree, S.G.3
-
61
-
-
0036144454
-
Thrombospndin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: Association with p53 alterations, tumor angiogenesis, and tumor progression
-
Grossfeld, G.D.; Carroll, P.R.; Lindeman, N.; Meng, M.; Groshen, S.; Feng, A-C.; Hawes, D.; Cote, R.J. Thrombospndin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: Association with p53 alterations, tumor angiogenesis, and tumor progression. Urology 2002, 59, 97-102.
-
(2002)
Urology
, vol.59
, pp. 97-102
-
-
Grossfeld, G.D.1
Carroll, P.R.2
Lindeman, N.3
Meng, M.4
Groshen, S.5
Feng, A.-C.6
Hawes, D.7
Cote, R.J.8
-
62
-
-
19944428379
-
Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate
-
Colombel, M.; Filleur, S.; Fournier, P.; Merle, C.; Guglielmi, J.; Courtin, A.; Degeorges, A.; Serre, C.M.; Bouvier, R.; Clézardin, P.; et al. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate. Cancer Res. 2005, 65, 300-308.
-
(2005)
Cancer Res
, vol.65
, pp. 300-308
-
-
Colombel, M.1
Filleur, S.2
Fournier, P.3
Merle, C.4
Guglielmi, J.5
Courtin, A.6
Degeorges, A.7
Serre, C.M.8
Bouvier, R.9
Clézardin, P.10
-
63
-
-
0036178598
-
Thorombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia
-
Kwak, C.; Jin, R.J.; Lee, C.; Park, M.S.; Lee, S.E. Thorombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia. BJU Int. 2002, 89, 303-309.
-
(2002)
BJU Int
, vol.89
, pp. 303-309
-
-
Kwak, C.1
Jin, R.J.2
Lee, C.3
Park, M.S.4
Lee, S.E.5
-
64
-
-
2942756097
-
The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostatic cancer
-
Vallbo, C.; Wang, W.; Damber, J.-E. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostatic cancer. BJU Int. 2004, 92, 1339-1343.
-
(2004)
BJU Int
, vol.92
, pp. 1339-1343
-
-
Vallbo, C.1
Wang, W.2
Damber, J.-E.3
-
65
-
-
21644470940
-
Expression of thrombospondin-1 in prostate-derived cell lines
-
Bastian, M.; Steiner, M.; Schuff-Werner, P. Expression of thrombospondin-1 in prostate-derived cell lines. Int. J. Mol. Med. 2005, 15, 49-56.
-
(2005)
Int. J. Mol. Med
, vol.15
, pp. 49-56
-
-
Bastian, M.1
Steiner, M.2
Schuff-Werner, P.3
-
66
-
-
34548446819
-
Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue
-
Kaygusuz, G.; Tulunay, O.; Baltaci, S.; Gogus, O. Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue. Int. Urol. Nephrol. 2007, 39, 841-850.
-
(2007)
Int. Urol. Nephrol
, vol.39
, pp. 841-850
-
-
Kaygusuz, G.1
Tulunay, O.2
Baltaci, S.3
Gogus, O.4
-
67
-
-
34547108838
-
Androgen receptor target NFkappaB and TSP1 to suppress prostate tumor growth in vivo
-
Nelius, T.; Filleur, S.; Yemelyanov, A.; Budunov, A.; Budunoval, I.; Shroff, E.; Mirochnik, Y.; Aurora, A.; Veliceasa, D.; Xiao, W.; et al. Androgen receptor target NFkappaB and TSP1 to suppress prostate tumor growth in vivo. Int. J. Cancer 2007, 121, 999-1008.
-
(2007)
Int. J. Cancer
, vol.121
, pp. 999-1008
-
-
Nelius, T.1
Filleur, S.2
Yemelyanov, A.3
Budunov, A.4
Budunoval, I.5
Shroff, E.6
Mirochnik, Y.7
Aurora, A.8
Veliceasa, D.9
Xiao, W.10
-
68
-
-
67650466367
-
Beta 1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1
-
Goel, H.L.; Moro, L.; Murphy-Ullrich, J.E.; Hsieh, C.C.; Wu, C.L.; Jiang, Z.; Languino, L.R. Beta 1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1. Cancer Res. 2009, 69, 5374-5382.
-
(2009)
Cancer Res
, vol.69
, pp. 5374-5382
-
-
Goel, H.L.1
Moro, L.2
Murphy-Ullrich, J.E.3
Hsieh, C.C.4
Wu, C.L.5
Jiang, Z.6
Languino, L.R.7
-
69
-
-
0035138955
-
Independent association of angiogenesis index with outcome in prostate cancer
-
Mehta, R; Kyshtoobayeva, A.; Kurosaki, T.; Small, E.J.; Kim, H.; Stroup, R.; McLaren, C.E.; Li, K.-T.; Fruehauf, J.P. Independent association of angiogenesis index with outcome in prostate cancer. Clin. Cancer Res. 2001, 7, 81-88.
-
(2001)
Clin. Cancer Res
, vol.7
, pp. 81-88
-
-
Mehta, R.1
Kyshtoobayeva, A.2
Kurosaki, T.3
Small, E.J.4
Kim, H.5
Stroup, R.6
McLaren, C.E.7
Li, K.-T.8
Fruehauf, J.P.9
-
70
-
-
77952314185
-
Mapping pro- and antiangiogenic factors on the surface of proteasomes of normal and malignant cell origin
-
Babiker, A.A.; Magnusson, P.U.; Ronquist, G; Nilsson, B.; Ekdahl, K.N. Mapping pro- and antiangiogenic factors on the surface of proteasomes of normal and malignant cell origin. Prostate 2010, 70, 834-847.
-
(2010)
Prostate
, vol.70
, pp. 834-847
-
-
Babiker, A.A.1
Magnusson, P.U.2
Ronquist, G.3
Nilsson, B.4
Ekdahl, K.N.5
-
71
-
-
0012174831
-
Expression of thrombospondin-derived 4N1K peptide-containing proteins in renal cell carcinoma tissues is associated with a decrease in tumor growth and angiogenesis
-
Miyata, Y.; Koga, S.; Takehara, K.; Kanetake, H.; Kanda, S. Expression of thrombospondin-derived 4N1K peptide-containing proteins in renal cell carcinoma tissues is associated with a decrease in tumor growth and angiogenesis. Clin. Cancer Res. 2003, 9, 1734-1740.
-
(2003)
Clin. Cancer Res
, vol.9
, pp. 1734-1740
-
-
Miyata, Y.1
Koga, S.2
Takehara, K.3
Kanetake, H.4
Kanda, S.5
-
72
-
-
34249937774
-
Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma
-
Klatte, T.; Böhm, M.; Nelius, T.; Filleur, S.; Reiher, F.; Allhoff, E.P. Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma. BJU Int. 2007, 100, 209-214.
-
(2007)
BJU Int
, vol.100
, pp. 209-214
-
-
Klatte, T.1
Böhm, M.2
Nelius, T.3
Filleur, S.4
Reiher, F.5
Allhoff, E.P.6
-
73
-
-
36749060817
-
Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma
-
Veliceasa, D.; Ivanovic, M.; Hoepfner, F.T.-S.; Thumbikat, P.; Volpert, O.V.; Smith, N.D. Transient potential receptor channel 4 controls thrombospondin-1 secretion and angiogenesis in renal cell carcinoma. FEBS J. 2007, 274, 6365-6377.
-
(2007)
FEBS J
, vol.274
, pp. 6365-6377
-
-
Veliceasa, D.1
Ivanovic, M.2
Hoepfner, F.T.-S.3
Thumbikat, P.4
Volpert, O.V.5
Smith, N.D.6
-
74
-
-
70350438226
-
The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: Its relationship to angiogenesis, cell proliferation and cancer specific survival
-
Zubac, D.P.; Bostad, L.; Kihl, B.; Seidal, T.; Wentzel-Larsen, T.; Haukaas, S.A. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: Its relationship to angiogenesis, cell proliferation and cancer specific survival. J. Urol. 2009, 182, 2144-2149.
-
(2009)
J. Urol
, vol.182
, pp. 2144-2149
-
-
Zubac, D.P.1
Bostad, L.2
Kihl, B.3
Seidal, T.4
Wentzel-Larsen, T.5
Haukaas, S.A.6
-
75
-
-
78649536407
-
Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy
-
Zubac, D.P.; Wentzel-Larsen, T.; Seidal, T.; Bostad, L. Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy. BMC Cancer 2010, 10, 20-25.
-
(2010)
BMC Cancer
, vol.10
, pp. 20-25
-
-
Zubac, D.P.1
Wentzel-Larsen, T.2
Seidal, T.3
Bostad, L.4
-
76
-
-
0038606823
-
Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality
-
Baltaci, S.B.; Orhan, D.; Gö and #x11F;üş, Ç.; Filiz, E.; Tulunay, Ö.; Gö and #x11F;üş, O. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality. Eur. Urol. 2003, 44, 76-81.
-
(2003)
Eur. Urol
, vol.44
, pp. 76-81
-
-
Baltaci, S.B.1
Orhan, D.2
Göüş, C.3
Filiz, E.4
Tulunay, O.5
Göüş, O.6
-
77
-
-
84869155165
-
Autocrine stimulation of clear-cell renal cell carcinoma cell migration in hypoxia via HJF-independent suppression of thrombospondin-1
-
doi:10.1038/ srep00788
-
Bienes-Martínez, R; Ordóńz, A.; Feijoo-Cuaresma, M.; Corral-Escariz, M.; Mateo, G; Stenina, O.; Jiménez, B.; Calzada, M.J. Autocrine stimulation of clear-cell renal cell carcinoma cell migration in hypoxia via HJF-independent suppression of thrombospondin-1. Sci. Rep. 2012, 2, doi:10.1038/ srep00788.
-
(2012)
Sci. Rep
, vol.2
-
-
Bienes-Martínez, R.1
Ordóńz, A.2
Feijoo-Cuaresma, M.3
Corral-Escariz, M.4
Mateo, G.5
Stenina, O.6
Jiménez, B.7
Calzada, M.J.8
-
78
-
-
76249092135
-
Variable inhibition of thrombospondin 1 against liver and lung metastases though differential activation of metalloproteinase ADAMTS1
-
Lee, Y.J.; Koch, M.; Karl, D.; Torres-Collado, A.X.; Fernando, N.T.; Rothrock, C; Kuruppu, D.; Ryeom, S.; Iruela-Arispe, M.L.; Yoon, S.S. Variable inhibition of thrombospondin 1 against liver and lung metastases though differential activation of metalloproteinase ADAMTS1. Cancer Res. 2010, 70, 948-956.
-
(2010)
Cancer Res
, vol.70
, pp. 948-956
-
-
Lee, Y.J.1
Koch, M.2
Karl, D.3
Torres-Collado, A.X.4
Fernando, N.T.5
Rothrock, C.6
Kuruppu, D.7
Ryeom, S.8
Iruela-Arispe, M.L.9
Yoon, S.S.10
-
79
-
-
0033940377
-
Current concepts and treatment of bladder cancer
-
Hassen, W.; Droller, M.J. Current concepts and treatment of bladder cancer. Curr. Opin. Urol. 2000, 10, 291-299.
-
(2000)
Curr. Opin. Urol
, vol.10
, pp. 291-299
-
-
Hassen, W.1
Droller, M.J.2
-
80
-
-
18744423089
-
Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression
-
Grossfeld, G.D.; Ginsberg, D.A.; Stein, J.P.; Bochner, B.H.; Esrig, D.; Groshen, S.; Dunn, M.; Nichols, P.W.; Taylor, C.R.; Skinner, D.G.; et al. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression. J. Natl. Cancer Inst. 1997, 89, 219-227.
-
(1997)
J. Natl. Cancer Inst
, vol.89
, pp. 219-227
-
-
Grossfeld, G.D.1
Ginsberg, D.A.2
Stein, J.P.3
Bochner, B.H.4
Esrig, D.5
Groshen, S.6
Dunn, M.7
Nichols, P.W.8
Taylor, C.R.9
Skinner, D.G.10
-
81
-
-
0036856030
-
Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer
-
Goddard, J.C.; Sutton, C.D.; Jones, J.L.; O'Byrne, K.J.; Kochelbergh, R.C. Reduced thrombospondin-1 at presentation predicts disease progression in superficial bladder cancer. Eur. Urol. 2002, 42, 464-468.
-
(2002)
Eur. Urol
, vol.42
, pp. 464-468
-
-
Goddard, J.C.1
Sutton, C.D.2
Jones, J.L.3
O'Byrne, K.J.4
Kochelbergh, R.C.5
-
82
-
-
33747146383
-
Thrombospondin-1 expression in urothelial carcinoma: Prognostic significance and association with p53 alterlations, tumour angiogenesis and extracellular matrix components
-
Ioachim, E.; Michael, M.C.; Salmas, M.; Damala, K.; tsanou, E.; Michael, M.M.; Malamou-Mitsi, V.; Stavropoulos, N.E. Thrombospondin-1 expression in urothelial carcinoma: Prognostic significance and association with p53 alterlations, tumour angiogenesis and extracellular matrix components. BMC Cancer 2006, 6, 140-147.
-
(2006)
BMC Cancer
, vol.6
, pp. 140-147
-
-
Ioachim, E.1
Michael, M.C.2
Salmas, M.3
Damala, K.4
Tsanou, E.5
Michael, M.M.6
Malamou-Mitsi, V.7
Stavropoulos, N.E.8
-
83
-
-
64749110334
-
Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radial cystectomy
-
Beecken, W.-D.; Engl, T.; Jonas, D.; Blaheta, R.A. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radial cystectomy. Int. J. Mol. Med. 2009, 23, 261-266.
-
(2009)
Int. J. Mol. Med
, vol.23
, pp. 261-266
-
-
Beecken, W.-D.1
Engl, T.2
Jonas, D.3
Blaheta, R.A.4
-
84
-
-
44049101630
-
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: A role for thrombospondin-1
-
doi:10.1186/1471-2490-8-7
-
Johnson, A.M.; O'Connell, M.J.; Miyamoto, H.; Huang, J.; Yao, J.L.; Messing, E.M.; Reeder, J.E. Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: A role for thrombospondin-1. BMC Urol. 2008, 8, doi:10.1186/1471-2490-8-7.
-
(2008)
BMC Urol
, vol.8
-
-
Johnson, A.M.1
O'Connell, M.J.2
Miyamoto, H.3
Huang, J.4
Yao, J.L.5
Messing, E.M.6
Reeder, J.E.7
-
85
-
-
84864913315
-
Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression
-
doi:10.1186/1471-2490-12-21
-
Byler, T.K.; Leocadio, D.; Shapiro, O.; Bratslavsky, G.; Stodgell, C.J.; Wood, R.W.; Messing, E.M.; Reeder, J.E. Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression. BMC Urol. 2012, 12, doi:10.1186/1471-2490-12-21.
-
(2012)
BMC Urol
, vol.12
-
-
Byler, T.K.1
Leocadio, D.2
Shapiro, O.3
Bratslavsky, G.4
Stodgell, C.J.5
Wood, R.W.6
Messing, E.M.7
Reeder, J.E.8
-
86
-
-
75549086130
-
Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas
-
Donmez, G.; Sullu, Y.; Baris, S.; Yildiz, L.; Aydin, O.; Karagoz, F.; Kandemir, B. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas. Pathol. Res. Pract. 2009, 205, 854-857.
-
(2009)
Pathol. Res. Pract
, vol.205
, pp. 854-857
-
-
Donmez, G.1
Sullu, Y.2
Baris, S.3
Yildiz, L.4
Aydin, O.5
Karagoz, F.6
Kandemir, B.7
-
87
-
-
77950518406
-
Associated of angiogenesis related markers with bladder cancer outcomes and other molecular markers
-
Shariat, S.F.; Youssef, R.F.; Gupta, A.; Chade, D.C.; Karakiewicz, P.I.; Isbarn, H.; Jeldres, C.; Sagalowsky, A.I.; Ashfaq, R.; Lotan, Y. Associated of angiogenesis related markers with bladder cancer outcomes and other molecular markers. J. Urol. 2010, 183, 1744-1750.
-
(2010)
J. Urol
, vol.183
, pp. 1744-1750
-
-
Shariat, S.F.1
Youssef, R.F.2
Gupta, A.3
Chade, D.C.4
Karakiewicz, P.I.5
Isbarn, H.6
Jeldres, C.7
Sagalowsky, A.I.8
Ashfaq, R.9
Lotan, Y.10
-
88
-
-
0023028858
-
Tissue plasminogen activator and urokinase enhances the binding of plasminogen to thrombospondin
-
Silverstein, R.; Harpel, P.C.; Nachman, R.L. Tissue plasminogen activator and urokinase enhances the binding of plasminogen to thrombospondin. J. Biol. Chem. 1986, 261, 9959-9965.
-
(1986)
J. Biol. Chem
, vol.261
, pp. 9959-9965
-
-
Silverstein, R.1
Harpel, P.C.2
Nachman, R.L.3
-
89
-
-
0034644748
-
Thrombospondin type I repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity
-
Bein, K.; Simons, M. Thrombospondin type I repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity. J. Biol. Chem. 2000, 275, 32167-32173.
-
(2000)
J. Biol. Chem
, vol.275
, pp. 32167-32173
-
-
Bein, K.1
Simons, M.2
-
90
-
-
19944428578
-
Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2·TIMP-2 complex through a thrombospondin-independent mechanism
-
Emonard, H.; Bellon, G.; Troeberg, L.; Berton, A.; Robinet, A.; Henriet, P.; Marbaix, E.; Kirkegaard, K.; Patthy, L.; Eeckhout, Y.; et al. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2·TIMP-2 complex through a thrombospondin-independent mechanism. J. Biol. Chem. 2004, 279, 54944-54951.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 54944-54951
-
-
Emonard, H.1
Bellon, G.2
Troeberg, L.3
Berton, A.4
Robinet, A.5
Henriet, P.6
Marbaix, E.7
Kirkegaard, K.8
Patthy, L.9
Eeckhout, Y.10
-
91
-
-
0042170209
-
Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration
-
Orr, A.W.; Elzie, C.A.; Kucik, D.F.; Murphy-Ullrich, J.E. Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J. Cell Sci. 2003, 116, 2917-2927.
-
(2003)
J. Cell Sci
, vol.116
, pp. 2917-2927
-
-
Orr, A.W.1
Elzie, C.A.2
Kucik, D.F.3
Murphy-Ullrich, J.E.4
-
92
-
-
70350572374
-
Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: Exploring the functional significance in tumor cell invasion
-
John, A.S.; Hu, X.; Rothman, V.L.; Tuszynski, G.P. Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: Exploring the functional significance in tumor cell invasion. Exp. Mol. Pathol. 2009, 87, 184-188.
-
(2009)
Exp. Mol. Pathol
, vol.87
, pp. 184-188
-
-
John, A.S.1
Hu, X.2
Rothman, V.L.3
Tuszynski, G.P.4
-
93
-
-
0028821827
-
Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis
-
Soff, G.A.; Sanderowitz, J.; Gately, S.; Verrusio, E.; Weiss, I.; Berm, S.; Kwaan, H.C. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis. J. Clin. Invest. 1995, 96, 2593-2600.
-
(1995)
J. Clin. Invest
, vol.96
, pp. 2593-2600
-
-
Soff, G.A.1
Sanderowitz, J.2
Gately, S.3
Verrusio, E.4
Weiss, I.5
Berm, S.6
Kwaan, H.C.7
-
94
-
-
22144436254
-
Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator recptor and plasminogen activator inhibitors in patients with renal cell carcinoma: Correlation with tumor associated macrophage and prognosis
-
Ohba, K.; Miyata, Y.; Kanda, S.; Koga, S.; Hayashi, T.; Kanetake, H. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator recptor and plasminogen activator inhibitors in patients with renal cell carcinoma: Correlation with tumor associated macrophage and prognosis. J. Urol. 2005, 174, 461-465.
-
(2005)
J. Urol
, vol.174
, pp. 461-465
-
-
Ohba, K.1
Miyata, Y.2
Kanda, S.3
Koga, S.4
Hayashi, T.5
Kanetake, H.6
-
95
-
-
0028060380
-
Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
-
Demeron, K.M.; Volpert, O.V.; Tainsky, M.A.; Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994, 265, 1582-1584.
-
(1994)
Science
, vol.265
, pp. 1582-1584
-
-
Demeron, K.M.1
Volpert, O.V.2
Tainsky, M.A.3
Bouck, N.4
-
96
-
-
14444282619
-
Alterations in tumor suppressor gene p53 corelate with inhibition of thrombosponsin-1 gene expression in colon cancer cells
-
Tokunaga, T.; Nakamura, M.; Oshika, Y.; Tsuchida, T.; Kazuno, M.; Fukushima, Y.; Kawai, K.; Abe, Y.; Kijima, H.; Yamazaki, H.; et al. Alterations in tumor suppressor gene p53 corelate with inhibition of thrombosponsin-1 gene expression in colon cancer cells. Virchow. Arch. 1998, 433, 415-433.
-
(1998)
Virchow. Arch
, vol.433
, pp. 415-433
-
-
Tokunaga, T.1
Nakamura, M.2
Oshika, Y.3
Tsuchida, T.4
Kazuno, M.5
Fukushima, Y.6
Kawai, K.7
Abe, Y.8
Kijima, H.9
Yamazaki, H.10
-
97
-
-
17344365783
-
Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma
-
Kawahara, N.; Ono, M.; Taguchi, K.; Okamoto, M.; Shimada, M.; Takenaka, K.; Hayashi, K.; Mosher, D.F.; Sugimachi, K.; Tsuneyoshi, M.; et al. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology 1998, 28, 1512-1517.
-
(1998)
Hepatology
, vol.28
, pp. 1512-1517
-
-
Kawahara, N.1
Ono, M.2
Taguchi, K.3
Okamoto, M.4
Shimada, M.5
Takenaka, K.6
Hayashi, K.7
Mosher, D.F.8
Sugimachi, K.9
Tsuneyoshi, M.10
-
98
-
-
40449133598
-
Thrombospondins in cancer
-
Kazerounian, S.; Yee, K.O.; Lawler, J. Thrombospondins in cancer. Cell. Mol. Life Sci. 2008, 65, 700-712.
-
(2008)
Cell. Mol. Life Sci
, vol.65
, pp. 700-712
-
-
Kazerounian, S.1
Yee, K.O.2
Lawler, J.3
-
99
-
-
11144308026
-
Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells
-
Scarpino, S.; Di Napoli, A.; Taraboletti, G.; Cancrini, A.; Ruco, L.P. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells. J. Pathol. 2005, 205, 50-56.
-
(2005)
J. Pathol
, vol.205
, pp. 50-56
-
-
Scarpino, S.1
Di, N.A.2
Taraboletti, G.3
Cancrini, A.4
Ruco, L.P.5
-
100
-
-
84856262662
-
Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features
-
Wei, W.; Kong, B.; Qu, X. Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features. J. Obstet. Gynaecol. Res. 2012, 38, 57-64.
-
(2012)
J. Obstet. Gynaecol. Res
, vol.38
, pp. 57-64
-
-
Wei, W.1
Kong, B.2
Qu, X.3
-
101
-
-
75749083670
-
Hepatocyte growth factor enhances ovarian cancer cell invasion through down-regulation of thrombospondin-1
-
Wei, W.; Kong, B.; Yang, Q.; Qu, X. Hepatocyte growth factor enhances ovarian cancer cell invasion through down-regulation of thrombospondin-1. Cancer Biol. Ther. 2010, 9, 79-87.
-
(2010)
Cancer Biol. Ther
, vol.9
, pp. 79-87
-
-
Wei, W.1
Kong, B.2
Yang, Q.3
Qu, X.4
-
102
-
-
60649085175
-
The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer
-
doi:10.1186/1471-2407-8-369
-
Weber, A.; Kristiansen, I.; Johannsen, M.; Oelrich, B.; Scholmann, K.; Gunia, S.; May, M.; Meyer, H.A.; Behnke, S.; Moch, H.; et al. The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer 2008, 8, doi:10.1186/1471-2407-8-369.
-
(2008)
BMC Cancer
, vol.8
-
-
Weber, A.1
Kristiansen, I.2
Johannsen, M.3
Oelrich, B.4
Scholmann, K.5
Gunia, S.6
May, M.7
Meyer, H.A.8
Behnke, S.9
Moch, H.10
-
103
-
-
56349103536
-
MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells
-
Tang, S.W.; Chang, W.H.; Su, Y.C.; Chen, Y.C.; Lai, Y.H.; Wu, P.T.; Hsu, C.I.; Lin, W.C.; Lai, M.K.; Lin, J.Y. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Cancer Lett. 2009, 273, 35-43.
-
(2009)
Cancer Lett
, vol.273
, pp. 35-43
-
-
Tang, S.W.1
Chang, W.H.2
Su, Y.C.3
Chen, Y.C.4
Lai, Y.H.5
Wu, P.T.6
Hsu, C.I.7
Lin, W.C.8
Lai, M.K.9
Lin, J.Y.10
-
104
-
-
0031059179
-
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization
-
Jenkins, R.B.; Qian, J.; Lieber, M.M.; Bostwick, D.G. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res. 1997, 57, 524-531.
-
(1997)
Cancer Res
, vol.57
, pp. 524-531
-
-
Jenkins, R.B.1
Qian, J.2
Lieber, M.M.3
Bostwick, D.G.4
-
105
-
-
28044441874
-
High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancer
-
Zaharieva, B.; Simon, R.; Ruiz, C.; Oeggerli, M.; Mihatsch, M.J.; Gasser, T.; Sauter, G.; Toncheva, D. High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancer. Int. J. Cancer 2005, 117, 952-956.
-
(2005)
Int. J. Cancer
, vol.117
, pp. 952-956
-
-
Zaharieva, B.1
Simon, R.2
Ruiz, C.3
Oeggerli, M.4
Mihatsch, M.J.5
Gasser, T.6
Sauter, G.7
Toncheva, D.8
-
106
-
-
84863415971
-
MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma
-
Yamamura, S.; Saini, S.; Majid, S.; Hirata, H.; Ueno, K.; Chang, I.; Tanaka, Y.; Gupta, A.; Dahiya, R. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis 2012, 33, 294-300.
-
(2012)
Carcinogenesis
, vol.33
, pp. 294-300
-
-
Yamamura, S.1
Saini, S.2
Majid, S.3
Hirata, H.4
Ueno, K.5
Chang, I.6
Tanaka, Y.7
Gupta, A.8
Dahiya, R.9
-
107
-
-
84874502379
-
Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma
-
Yamada, Y.; Hidaka, H.; Seki, N.; Yoshino, H.; Yamasaki, T.; Itesako, T.; Nakagawa, M.; Enokida, H. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. Cancer Sci. 2013, 104, 304-312.
-
(2013)
Cancer Sci
, vol.104
, pp. 304-312
-
-
Yamada, Y.1
Hidaka, H.2
Seki, N.3
Yoshino, H.4
Yamasaki, T.5
Itesako, T.6
Nakagawa, M.7
Enokida, H.8
-
108
-
-
10544235440
-
Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene
-
Tikhonenko, A.T.; Black, D.J.; Linial, M.L. Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J. Biol. Chem. 1996, 271, 30741-30747.
-
(1996)
J. Biol. Chem
, vol.271
, pp. 30741-30747
-
-
Tikhonenko, A.T.1
Black, D.J.2
Linial, M.L.3
-
109
-
-
0034209874
-
Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA
-
Janz, A.; Sevignani, C.; Kenyon, K.; Ngo, C.V.; Thomas-Tikhonenko, A. Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA. Nucleic Acids Res. 2000, 28, 2268-2275.
-
(2000)
Nucleic Acids Res
, vol.28
, pp. 2268-2275
-
-
Janz, A.1
Sevignani, C.2
Kenyon, K.3
Ngo, C.V.4
Thomas-Tikhonenko, A.5
-
110
-
-
78049276723
-
Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma
-
Zhou, L.; Picard, D.; Ra, Y.S.; Li, M.; Northcott, P.A.; Hu, Y.; Stearns, D.; Hawkins, C.; Taylor, M.D.; Rutka, J.; et al. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma. Cancer Res. 2010, 70, 8199-8210.
-
(2010)
Cancer Res
, vol.70
, pp. 8199-8210
-
-
Zhou, L.1
Picard, D.2
Ra, Y.S.3
Li, M.4
Northcott, P.A.5
Hu, Y.6
Stearns, D.7
Hawkins, C.8
Taylor, M.D.9
Rutka, J.10
-
111
-
-
0028089956
-
Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines
-
Zabrenetzky, V.; Harris, C.C.; Steeg, P.S.; Roberts, D.D. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines. Int. J. Cancer 1994, 59, 191-195.
-
(1994)
Int. J. Cancer
, vol.59
, pp. 191-195
-
-
Zabrenetzky, V.1
Harris, C.C.2
Steeg, P.S.3
Roberts, D.D.4
-
112
-
-
0028609624
-
Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis
-
Weinstat-Saslow, D.L.; Zabrenetzky, V.S.; VanHoutte, K.; Fraizier, W.A.; Roberts, D.D.; Steeg, P.S. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 1994, 54, 6504-6511.
-
(1994)
Cancer Res
, vol.54
, pp. 6504-6511
-
-
Weinstat-Saslow, D.L.1
Zabrenetzky, V.S.2
Vanhoutte, K.3
Fraizier, W.A.4
Roberts, D.D.5
Steeg, P.S.6
-
113
-
-
0028138632
-
SPARC and thrombospondin genes are repressed by c-jun oncogene in rat emryo fibroblasts
-
Mettouchi, A.; Cabon, F.; Montreau, N.; Vernier, P.; Mercier, G.; Blangy, D.; Tricoire, H.; Vigier, P.; Binétruy, B. SPARC and thrombospondin genes are repressed by c-jun oncogene in rat emryo fibroblasts. EMBO J. 1994, 13, 5668-5678.
-
(1994)
EMBO J
, vol.13
, pp. 5668-5678
-
-
Mettouchi, A.1
Cabon, F.2
Montreau, N.3
Vernier, P.4
Mercier, G.5
Blangy, D.6
Tricoire, H.7
Vigier, P.8
Binétruy, B.9
-
114
-
-
27644525709
-
Suppression of tumour cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1
-
Moon, Y.; Bottone, F.G.; McEntee, M.F.; Gahtan, V. Suppression of tumour cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Mol. Cancer Ther. 2005, 5, 1551-1558.
-
(2005)
Mol. Cancer Ther
, vol.5
, pp. 1551-1558
-
-
Moon, Y.1
Bottone, F.G.2
McEntee, M.F.3
Gahtan, V.4
-
115
-
-
33646136232
-
Regulation of thrombospondin-1
-
Ren, B.; Yee, K.O.; Lawler, J.; Khosravi-Far, R. Regulation of thrombospondin-1. Biochem. Biophys. Acta. 2006, 1765, 178-188.
-
(2006)
Biochem. Biophys. Acta
, vol.1765
, pp. 178-188
-
-
Ren, B.1
Yee, K.O.2
Lawler, J.3
Khosravi-Far, R.4
-
116
-
-
75149141252
-
Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53
-
Su, F.; Pascal, L.E.; Xiao, W.; Wang, Z. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53. Oncogene 2010, 29, 421-431.
-
(2010)
Oncogene
, vol.29
, pp. 421-431
-
-
Su, F.1
Pascal, L.E.2
Xiao, W.3
Wang, Z.4
-
117
-
-
0030724993
-
Genes regulated by androgen in the rate ventral prostate
-
Wang, Z.; Tufts, R.; Haleem, R.; Cai, X. Genes regulated by androgen in the rate ventral prostate. Proc. Natl. Acad. Sci. USA 1997, 94, 12999-13004.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 12999-13004
-
-
Wang, Z.1
Tufts, R.2
Haleem, R.3
Cai, X.4
-
118
-
-
0041633811
-
Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptotic inducer
-
Xiao, W.; Zhang, Q.; Jiang, F.; Pins, M.; Kozlowski, J.M.; Wang, Z. Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptotic inducer. Cancer Res. 2003, 63, 4698-4704.
-
(2003)
Cancer Res
, vol.63
, pp. 4698-4704
-
-
Xiao, W.1
Zhang, Q.2
Jiang, F.3
Pins, M.4
Kozlowski, J.M.5
Wang, Z.6
-
119
-
-
78649879269
-
-
Kaur, S.; Martin-Manso, G.; Pendrak, M.L.; Garfield, S.H.; Isenberg, J.S.; Roberts, D.D. Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J. Biol. Chem. 2010, 285, 38923-38932.
-
(2010)
Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling By Disrupting Its Association With CD47
, vol.285
, pp. 38923-38932
-
-
Kaur, S.1
Martin-Manso, G.2
Pendrak, M.L.3
Garfield, S.H.4
Isenberg, J.S.5
Roberts, D.D.6
-
120
-
-
0030904193
-
Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induced apoptosis of endothelial cells
-
Guo, N.-H.; Krutzsch, H.C.; Inman, J.K.; Robert, D.D. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induced apoptosis of endothelial cells. Cancer Res. 1997, 57, 1735-1742.
-
(1997)
Cancer Res
, vol.57
, pp. 1735-1742
-
-
Guo, N.-H.1
Krutzsch, H.C.2
Inman, J.K.3
Robert, D.D.4
-
121
-
-
17444405974
-
Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induces promyelocytic leukemia cell differentiation and apoptosis
-
Bruel, A.; Touhami-Carrier, A.; Thomaidis, A.; Legrand, C. Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induces promyelocytic leukemia cell differentiation and apoptosis. Anticancer Res. 2005, 25, 757-764.
-
(2005)
Anticancer Res
, vol.25
, pp. 757-764
-
-
Bruel, A.1
Touhami-Carrier, A.2
Thomaidis, A.3
Legrand, C.4
-
122
-
-
0027290714
-
Peptodes derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
-
Tolsma, S.S.; Volpert, O.V.; Good, D.J.; Frazier, W.A.; Polverini, P.J.; Bouck, N.P. Peptodes derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 1993, 122, 497-511.
-
(1993)
J. Cell Biol
, vol.122
, pp. 497-511
-
-
Tolsma, S.S.1
Volpert, O.V.2
Good, D.J.3
Frazier, W.A.4
Polverini, P.J.5
Bouck, N.P.6
-
123
-
-
34547604817
-
TRP channels in cancer
-
Prevarskaya, N.; Zhang, L.; Barritt, G. TRP channels in cancer. Biochem. Biophys. Acta 2007, 1772, 937-946.
-
(2007)
Biochem. Biophys. Acta
, vol.1772
, pp. 937-946
-
-
Prevarskaya, N.1
Zhang, L.2
Barritt, G.3
-
124
-
-
22144442812
-
Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death though CD47/α3 in promyelocytic leukemia NB4 cells
-
Saumet, A.; Slimane, B.M.; Lanotte, M.; Lawler, J.; Dubermrd, V. Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death though CD47/αv3 in promyelocytic leukemia NB4 cells. Blood 2005, 106, 658-667.
-
(2005)
Blood
, vol.106
, pp. 658-667
-
-
Saumet, A.1
Slimane, B.M.2
Lanotte, M.3
Lawler, J.4
Dubermrd, V.5
-
125
-
-
2442695451
-
Expression of thrombospondin 1 fragment 167-569 in C6 glioma cells stimulates tumorgenecity despite reduced neovascularization
-
De Fraipont, F.; Keramidas, M.; el Atifti, M.; Chambaz, E.M.; Berger, F.; Feige, J.-J. Expression of thrombospondin 1 fragment 167-569 in C6 glioma cells stimulates tumorgenecity despite reduced neovascularization. Oncogene 2004, 23, 3642-3649.
-
(2004)
Oncogene
, vol.23
, pp. 3642-3649
-
-
de Fraipont, F.1
Keramidas, M.2
El, A.M.3
Chambaz, E.M.4
Berger, F.5
Feige, J.-J.6
-
126
-
-
0842325791
-
CD47 mediates killing of breast tumor cell via Gi-dependent inhibitor of protein kinase A
-
Manna, P.P.; Frazier, W.A. CD47 mediates killing of breast tumor cell via Gi-dependent inhibitor of protein kinase A. Cancer Res. 2004, 64, 1026-1036.
-
(2004)
Cancer Res
, vol.64
, pp. 1026-1036
-
-
Manna, P.P.1
Frazier, W.A.2
-
127
-
-
34548821303
-
Thrombospondin-based antiangiogenic therapy
-
Zhang, X.; Lawler J. Thrombospondin-based antiangiogenic therapy. Microvasc. Res. 2007, 74, 90-99.
-
(2007)
Microvasc. Res
, vol.74
, pp. 90-99
-
-
Zhang, X.1
Lawler, J.2
-
128
-
-
34249990658
-
A phase II study of ABT-510 (thrombospondin-1 analogue) for the treatment of metastatic melanoma
-
Markovic, S.N.; Suman, V.J.; Rao, R.A.; Ingle, J.N.; Kaur, J.S.; Erickson, L.A.; Pitot, H.C.; Croghan, G.A.; McWilliams, R.R.; Merchan, J.; et al. A phase II study of ABT-510 (thrombospondin-1 analogue) for the treatment of metastatic melanoma. Am. J. Clin. Oncol. 2007, 30, 303-309.
-
(2007)
Am. J. Clin. Oncol
, vol.30
, pp. 303-309
-
-
Markovic, S.N.1
Suman, V.J.2
Rao, R.A.3
Ingle, J.N.4
Kaur, J.S.5
Erickson, L.A.6
Pitot, H.C.7
Croghan, G.A.8
McWilliams, R.R.9
Merchan, J.10
-
129
-
-
57149111052
-
Randomized phase II study of the thrombospondin-1-mimetic angiogenesis inhibitor abt-510 in patients with advanced soft tissue sarcoma
-
Baker, L.H.; Rowinsky, E.K.; Mendelson, D.; Humerickhouse, R.A.; Knight, RA; Qian, J.; Carr, RA; Gordon, G.B.; Demetri, G.D. Randomized phase II study of the thrombospondin-1-mimetic angiogenesis inhibitor abt-510 in patients with advanced soft tissue sarcoma. J. Clin. Oncol. 2008, 26, 5583-5588.
-
(2008)
J. Clin. Oncol
, vol.26
, pp. 5583-5588
-
-
Baker, L.H.1
Rowinsky, E.K.2
Mendelson, D.3
Humerickhouse, R.A.4
Knight, R.A.5
Qian, J.6
Carr, R.A.7
Gordon, G.B.8
Demetri, G.D.9
-
130
-
-
25144488561
-
Metronomic low-dose chemotherapy boots CD-95-dependent anti angiogenic effect of thrombospondin peptide ABT-510: A complementation antiangiogenic strategy
-
Yap, R.; Veliceasa, D.; Emmenegger, U.; Kerbel, R.S.; McKay, L.M.; Henkin, J.; Volpert, O.V. Metronomic low-dose chemotherapy boots CD-95-dependent anti angiogenic effect of thrombospondin peptide ABT-510: A complementation antiangiogenic strategy. Clin. Cancer Res. 2005, 15, 6678-6685.
-
(2005)
Clin. Cancer Res
, vol.15
, pp. 6678-6685
-
-
Yap, R.1
Veliceasa, D.2
Emmenegger, U.3
Kerbel, R.S.4
McKay, L.M.5
Henkin, J.6
Volpert, O.V.7
-
131
-
-
20944443196
-
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: Design, synthesis, and optimization of pharmacokinetics and biological activities
-
Haviv, F.; Bradley, M.F.; Kalvin, D.M.; Schneider, A.J.; Davidson, D.J.; Majest, S.M.; McKay, L.M.; Haskell, C.J.; Bell, R.L.; Nguyen, B.; et al. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: Design, synthesis, and optimization of pharmacokinetics and biological activities. J. Med. Chem. 2005, 48, 2838-2846.
-
(2005)
J. Med. Chem
, vol.48
, pp. 2838-2846
-
-
Haviv, F.1
Bradley, M.F.2
Kalvin, D.M.3
Schneider, A.J.4
Davidson, D.J.5
Majest, S.M.6
McKay, L.M.7
Haskell, C.J.8
Bell, R.L.9
Nguyen, B.10
-
132
-
-
36749060830
-
Phase 2 study of ABT-510 in patients with previouslu untreated advanced renal cell carcinoma
-
Ebbinghaus, S.; Hussain, M.; Tannir, N.; Gordon, M.; Desai, A.A.; Knight, R.A.; Humerickhouse, R.A.; Quian, J.; Gordon, G.B.; Fliglin, R. Phase 2 study of ABT-510 in patients with previouslu untreated advanced renal cell carcinoma. Clin. Cancer Res. 2007, 13, 6689-6695.
-
(2007)
Clin. Cancer Res
, vol.13
, pp. 6689-6695
-
-
Ebbinghaus, S.1
Hussain, M.2
Tannir, N.3
Gordon, M.4
Desai, A.A.5
Knight, R.A.6
Humerickhouse, R.A.7
Quian, J.8
Gordon, G.B.9
Fliglin, R.10
-
133
-
-
34248192988
-
The quinolone-3-carboxamaide anti-angiogenic agents, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts
-
Dalrymple, S.L.; Becker, R.E.; Issacs, J.T. The quinolone-3-carboxamaide anti-angiogenic agents, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts. Prostate 2007, 67, 790-797.
-
(2007)
Prostate
, vol.67
, pp. 790-797
-
-
Dalrymple, S.L.1
Becker, R.E.2
Issacs, J.T.3
-
134
-
-
70349952393
-
Open-rabel, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer
-
Bratt, O.; Haggman, M.; Ahlgren, G; Nordle, O.; Bjork, A.; Damber, J.E. Open-rabel, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer. Br. J. Cancer 2009, 101, 1233-1240.
-
(2009)
Br. J. Cancer
, vol.101
, pp. 1233-1240
-
-
Bratt, O.1
Haggman, M.2
Ahlgren, G.3
Nordle, O.4
Bjork, A.5
Damber, J.E.6
-
135
-
-
77952223624
-
Tasquinimod (ABR-215050), a quinolone-3-carboxamide anti-angiogenic agents, modulates the expression of thrombospondin-1 in human prostate tumors
-
doi:10.1186/1476-4598-9-107
-
Olsson, A.; Bjork, A.; Vallon-Christersson, J.; Issacs, J.T.; Leanderson, T. Tasquinimod (ABR-215050), a quinolone-3-carboxamide anti-angiogenic agents, modulates the expression of thrombospondin-1 in human prostate tumors. Mol. Cancer 2010, 9, doi:10.1186/1476-4598-9-107.
-
(2010)
Mol. Cancer
, vol.9
-
-
Olsson, A.1
Bjork, A.2
Vallon-Christersson, J.3
Issacs, J.T.4
Leanderson, T.5
-
136
-
-
84860319412
-
Inhibition of metastasis in a castration resistant prostate cancer model by the quinolone-3-carboxamide tasquinimod (ABR-215050)
-
Jennbacken, K.; Welén, K.; Olsson, A.; Axelsson, B.; Törngren, M.; Damber, J.E.; Leanderson, T. Inhibition of metastasis in a castration resistant prostate cancer model by the quinolone-3-carboxamide tasquinimod (ABR-215050). Prostate 2012, 72, 913-924.
-
(2012)
Prostate
, vol.72
, pp. 913-924
-
-
Jennbacken, K.1
Welén, K.2
Olsson, A.3
Axelsson, B.4
Törngren, M.5
Damber, J.E.6
Leanderson, T.7
-
137
-
-
84872735865
-
Blockade of CD47 increases survival of mice exposed to lethal total body irradiation
-
doi:10.1038/srep01038
-
Soto-Pantoja, D.R.; Ridnour, L.A.; Wink, D.A.; Roberts, D.D. Blockade of CD47 increases survival of mice exposed to lethal total body irradiation. Sci. Rep. 2013, 3, doi:10.1038/srep01038.
-
(2013)
Sci. Rep
, vol.3
-
-
Soto-Pantoja, D.R.1
Ridnour, L.A.2
Wink, D.A.3
Roberts, D.D.4
-
138
-
-
53149130570
-
Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury
-
Isenberg, J.S.; Maxhimer, J.B.; Hyodo, F.; Pendrak, M.L.; Ridnour, L.A.; DeGraff, W.G.; Tsokos, M.; Wink, D.A.; Roberts, D.D. Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. Am. J. Pathol. 2008, 173, 1100-1112.
-
(2008)
Am. J. Pathol
, vol.173
, pp. 1100-1112
-
-
Isenberg, J.S.1
Maxhimer, J.B.2
Hyodo, F.3
Pendrak, M.L.4
Ridnour, L.A.5
Degraff, W.G.6
Tsokos, M.7
Wink, D.A.8
Roberts, D.D.9
-
139
-
-
77951977531
-
Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling
-
doi:10.1126/scitranslmed.3000139
-
Maxhimer, J.B.; Soto-Pantoja, D.R.; Ridnour, L.A.; Shih, H.B.; Degraff, W.G.; Tsokos, M.; Wink, D.A.; Isenberg, J.S.; Roberts, D.D. Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci. Transl. Med. 2009, 1, doi:10.1126/scitranslmed.3000139.
-
(2009)
Sci. Transl. Med
, vol.1
-
-
Maxhimer, J.B.1
Soto-Pantoja, D.R.2
Ridnour, L.A.3
Shih, H.B.4
Degraff, W.G.5
Tsokos, M.6
Wink, D.A.7
Isenberg, J.S.8
Roberts, D.D.9
-
140
-
-
33749068226
-
The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells
-
Rath, G.M.; Schneider, C.; Dedieu, S.; Rothhut, B.; Soula-Rothhut, M.; Ghoneim, C.; Sid, C.B.; Morjani, H.; el Btaouri, H.; Martiny, L. The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochem. Biophys. Acta 2006, 1763, 1125-1134.
-
(2006)
Biochem. Biophys. Acta
, vol.1763
, pp. 1125-1134
-
-
Rath, G.M.1
Schneider, C.2
Dedieu, S.3
Rothhut, B.4
Soula-Rothhut, M.5
Ghoneim, C.6
Sid, C.B.7
Morjani, H.8
El, B.H.9
Martiny, L.10
-
141
-
-
84876587975
-
Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors
-
doi:10.1038/srep01673
-
Kaur, S.; Soto-Pantoja, D.R.; Stein, E.V.; Liu, C.; Elkahloun, A.G.; Pendrak, M.L.; Nicolae, A.; Singh, S.P.; Nie, Z.; Levens, D.; et al. Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors. Sci. Rep. 2013, 3, doi:10.1038/srep01673.
-
(2013)
Sci. Rep
, vol.3
-
-
Kaur, S.1
Soto-Pantoja, D.R.2
Stein, E.V.3
Liu, C.4
Elkahloun, A.G.5
Pendrak, M.L.6
Nicolae, A.7
Singh, S.P.8
Nie, Z.9
Levens, D.10
-
142
-
-
34548573208
-
Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia
-
Uno, S.; Kinoshita, Y.; Azuma, Y.; Tsunenari, T.; Yoshimura, Y.; Iida, S.; Kikuchi, Y.; Yamada-Okabe, H.; Fukushima, N. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia. Oncol. Rep. 2007, 17, 1189-1194.
-
(2007)
Oncol. Rep
, vol.17
, pp. 1189-1194
-
-
Uno, S.1
Kinoshita, Y.2
Azuma, Y.3
Tsunenari, T.4
Yoshimura, Y.5
Iida, S.6
Kikuchi, Y.7
Yamada-Okabe, H.8
Fukushima, N.9
-
143
-
-
0037051655
-
Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics
-
Reiher, F.K.; Volpert, O.V.; Jimenez, B.; Crawford, S.E.; Dinney, C.P.; Henkin, J.; Haviv, F.; Bouck, N.P.; Campbell, S.C. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. Int. J. Cancer 2002, 98, 682-689.
-
(2002)
Int. J. Cancer
, vol.98
, pp. 682-689
-
-
Reiher, F.K.1
Volpert, O.V.2
Jimenez, B.3
Crawford, S.E.4
Dinney, C.P.5
Henkin, J.6
Haviv, F.7
Bouck, N.P.8
Campbell, S.C.9
|